Stay updated on RPL554 MDI for COPD Treatment Clinical Trial
Sign up to get notified when there's something new on the RPL554 MDI for COPD Treatment Clinical Trial page.

Latest updates to the RPL554 MDI for COPD Treatment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3, signaling a new version snapshot of the study page content.SummaryDifference0.0%

- Check21 days agoChange DetectedThe sponsor field now lists Verona Pharma, Inc., a subsidiary of Merck & Co., Inc., as the sponsor. Verona Pharma plc is no longer referenced in the sponsor information.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page now shows a new revision tag (v3.5.3) replacing the previous (v3.5.2), signaling an administrative update. There are no changes to study content or results.SummaryDifference0.0%

- Check43 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check50 days agoChange DetectedUpdated the collaborator entry to IQVIA Pty Ltd, replacing Iqvia Pty Ltd.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision notes updated: added Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.0%

Stay in the know with updates to RPL554 MDI for COPD Treatment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RPL554 MDI for COPD Treatment Clinical Trial page.